THE THROMBOSIS RESEARCH INSTITUTE
Financial health, per its FY2023 accounts
The accounts state that unrestricted reserves stood at £7,010,689 against an annual unrestricted expenditure of £3,206,079, providing a reserve ratio of approximately 2.2 years. The Trustees consider the financial health of the Institute to be good, noting that it continues to attract funds to support its research and educational activities despite a net expenditure for the year.
What the accounts disclose
“In the band £190,001 - £200,000” — page 31
“Total amount paid to key management staff was £537,630” — page 31
“At the year-end, Patrick Burgess was a Trustee of the Institute and the Thrombosis Research Trust.” — page 5
“subsidiary undertakings as follows: TRI Technology Transfer Limited (intellectual property) TRI Clinical Trials Limited (research and development)”
Structured financials (annual return, FY ending 31/07/2025)
Trustees
- PATRICK BURGESS MBEchair
- GUY HOWARD WESTON
- LORD DAVID NEUBERGER
- Revd Dr Sir Ralph Waller
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/07/2025 | £3.4m | £3.2m |
| 31/07/2024 | £3.1m | £2.9m |
| 31/07/2023 | £1.7m | £3.2m |
| 31/07/2022 | £3.5m | £4.4m |
| 31/07/2021 | £3.3m | £6.9m |
Common questions
Is THE THROMBOSIS RESEARCH INSTITUTE financially healthy?
The accounts state that unrestricted reserves stood at £7,010,689 against an annual unrestricted expenditure of £3,206,079, providing a reserve ratio of approximately 2.2 years. The Trustees consider the financial health of the Institute to be good, noting that it continues to attract funds to support its research and educational activities despite a net expenditure for the year. Its FY2023 accounts were audited by Haysmacintyre LLP.
What does the highest-paid employee of THE THROMBOSIS RESEARCH INSTITUTE earn?
Per its FY2023 accounts, the highest-paid employee was in the £190,001 - £200,000 band, and 11 employees earned over £60,000.